Back to Gene
L1CAM gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

L1CAM gene

The L1CAM gene is responsible for producing a protein critical to nervous system development, including neuron organization, axon growth, and brain function.

Normal Function

The L1CAM gene provides instructions for producing the L1 cell adhesion molecule (L1 protein). This protein is found on the surface of neurons throughout the nervous system. By spanning the cell membrane, the L1 protein allows neurons to attach to one another, a process known as cell-cell adhesion.

The L1 protein is essential for several neurological processes:

  • Movement (migration) and organization of neurons.
  • Outgrowth of axons (extensions that transmit nerve impulses).
  • Formation of the protective myelin sheath.
  • Formation of synapses, where cell-to-cell communication occurs.

These functions are fundamental to brain development, memory, thinking ability, and movement.

Health Conditions Related to Genetic Changes

L1 syndrome

More than 350 mutations in the L1CAM gene cause L1 syndrome, a group of conditions primarily affecting the nervous system in males. Symptoms often include brain abnormalities, intellectual disability, and movement problems. Mutations disrupt the L1 protein's ability to facilitate cell adhesion, which impedes brain growth and development.

  • Severe cases: Often result from mutations that produce a nonfunctional, abnormally short protein or a complete absence of the protein.
  • Milder cases: Often result from mutations that change single amino acids, impairing the protein's ability to interact with other proteins or reach the cell surface.

Other disorders

Rarely, L1CAM mutations are found in individuals with both hydrocephalus (buildup of fluid in the brain) and Hirschsprung disease (an intestinal disorder characterized by the absence of nerves in parts of the intestine). It is believed these mutations disrupt nerve cell migration in both the brain and the intestine.

Frequently Asked Questions

Confirmation is achieved through DNA sequencing of the L1CAM gene, often as part of an X‑linked intellectual disability panel. The test can detect point mutations, insertions, deletions, or splice‑site changes. If a mutation is found, a repeat test on a parental sample clarifies whether it is inherited or de novo.
Hydrocephalus is typically managed with a ventriculoperitoneal shunt, with regular imaging to monitor shunt function. Spasticity can be treated with physical therapy, oral antispasticity medications (e.g., baclofen), or intrathecal baclofen pumps. Early intervention programs, occupational therapy, and speech therapy are essential for maximizing developmental potential.
Because L1CAM mutations are X‑linked, carrier females have a 50 % chance of passing the mutation to sons (who will be affected) and a 50 % chance to daughters (who will be carriers). Prenatal testing via chorionic villus sampling or amniocentesis can detect the mutation. Pre‑implantation genetic diagnosis (PGD) during in‑vitro fertilization allows selection of embryos without the mutation. Genetic counseling is recommended to discuss risks and options.===
Key signs include intellectual disability, spasticity or motor weakness, and a history of hydrocephalus requiring shunt placement. In males, a characteristic “X‑linked” inheritance pattern and a family history of similar neurological issues raise suspicion. Early MRI showing corpus callosum agenesis or thinning also supports the need for L1CAM genetic testing.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ